rs144015992
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_004733.4(SLC33A1):āc.1451A>Cā(p.Asn484Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00297 in 1,613,974 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_004733.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC33A1 | NM_004733.4 | c.1451A>C | p.Asn484Thr | missense_variant | 5/6 | ENST00000643144.2 | NP_004724.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC33A1 | ENST00000643144.2 | c.1451A>C | p.Asn484Thr | missense_variant | 5/6 | NM_004733.4 | ENSP00000496241 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00183 AC: 278AN: 152102Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00175 AC: 440AN: 251474Hom.: 0 AF XY: 0.00176 AC XY: 239AN XY: 135910
GnomAD4 exome AF: 0.00309 AC: 4510AN: 1461754Hom.: 6 Cov.: 31 AF XY: 0.00299 AC XY: 2175AN XY: 727178
GnomAD4 genome AF: 0.00183 AC: 278AN: 152220Hom.: 1 Cov.: 32 AF XY: 0.00132 AC XY: 98AN XY: 74430
ClinVar
Submissions by phenotype
not provided Benign:5
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 16, 2021 | This variant is associated with the following publications: (PMID: 31227335) - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | SLC33A1: BP4, BS1 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 06, 2021 | - - |
Spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | - - |
Hereditary spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Nov 03, 2020 | - - |
Hereditary spastic paraplegia 42;C4751114:Huppke-Brendel syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 08, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at